UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
HI-TECH PHARMACAL CO., INC.
-------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
-------------------------------------------------------------
(Title of Class of Securities)
42840B101
-------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 42840B101 13G Page 2 of 7 Pages
1. Name of Reporting Persons I.R.S. Identification Nos. of Above Persons
(entities only): Bernard Seltzer
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b) Not applicable
3. SEC Use Only
4. Citizenship or Place of Organization: United States
NUMBER OF SHARES 5. Sole Voting Power
738,226
BENEFICIALLY 6. Shared Voting Power
-0-
OWNED BY EACH 7. Sole Dispositive Power
738,226
REPORTING PERSON 8. Shared Dispositive Power
-0-
WITH
9. Aggregate Amount Beneficially Owned by Each Reporting Person
738,226
10. Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions) [ ]
11. Percent of Class Represented by Amount in Row (9)
16.3%
12. Type of Reporting Person (See Instructions) IN
<PAGE>
CUSIP NO. 42840B101 13G Page 3 of 7 Pages
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. __)
Under the Securities Exchange Act of 1934
HI-TECH PHARMACAL CO., INC.
(Name of Issuer)
Item 1(a)
---------
Name of Issuer: Hi-Tech Pharmacal Co., Inc.
Item 1(b)
---------
Address of Issuer's Principal Executive Offices: 369 Bayview Avenue,
Amityville, New York 11701
Item 2(a)
---------
Name of Person Filing: Bernard Seltzer
Item 2(b)
---------
Address of Principal Business Office or, if none, Residence: 369 Bayview
Avenue, Amityville, New York 11701
Item 2(c)
---------
Citizenship: United States
Item 2(d)
---------
Title of Class of Securities: Common Stock
<PAGE>
CUSIP NO. 42840B101 13G Page 4 of 7 Pages
Item 2(e)
---------
CUSIP Number: 42840B101
Item 3
------
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the person is a:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see ss.240.13d-1(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with
ss.240.13d-1(b)(ii)(G) (Note: See Item 7)
(h) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(H)
Not applicable
Item 4
------
Ownership:
(a) Amount Beneficially Owned:
738,226
................................................................
<PAGE>
CUSIP NO. 42840B101 13G Page 5 of 7 Pages
(b) Percent of Class:
16.3%
................................................................
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote.................738,226
(ii) shared power to vote or to direct the vote...................-0-
(iii)sole power to dispose or to direct the disposition of....738,226
(iv) shared power to dispose or to direct the disposition of......-0-
Item 5
-------
Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Item 6
------
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7
------
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company.
Not applicable
<PAGE>
CUSIP NO. 42840B101 13G Page 6 of 7 Pages
Item 8
------
Identification and Classification of Members of the Group.
Not applicable
Item 9
------
Notice of Dissolution of Group.
Not applicable
Item 10
-------
Certification:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction or having
such purposes or effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: February 10, 1998
/s/Bernard Seltzer
-------------------------------
Bernard Seltzer
